Literature DB >> 6411770

Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver.

H Saito, S M Hamilton, A S Tavill, L T Goodnough, L Louis, A Angell.   

Abstract

The site of synthesis of Hageman factor (HF, Factor XII) has not been previously demonstrated with certainty. We have studied the production and release of HF in the isolated perfused rat liver and have compared rates of synthesis in this system with absolute rates of degradation measured in vivo. Rat livers, perfused for 5 h with a recycling fluid consisting of a perfluorochemical emulsion (Fluosol 43), were used to demonstrate a cumulative increase of HF in the perfusate as measured by a specific and sensitive radioimmunoassay. The rate of increase in the perfusate pool of HF during the final 4 h of perfusion yielded a mean synthetic rate of 3.5 micrograms/h per 100 g body wt, which was approximately 0.2% of the synthetic rate of albumin in the same system. The cumulative appearance of albumin and transferrin was linear after 1 h and calculated rates of synthesis were 2,012 micrograms/h per 100 g and 263 micrograms/h per 100 g body wt, respectively. De novo synthesis of HF was confirmed by demonstrating incorporation of [14C]lysine into specific immunoprecipitates of HF, and by the observations that both specific incorporation of labeled amino acid and net release of immunoassayable HF were inhibited by the administration of cycloheximide. Finally, it was evident that the rates of synthesis observed in the isolated perfused liver agreed closely with absolute rates of degradation of HF measured in vivo with 125I-rat HF (4.0 micrograms/h per 100 g). From these data we conclude that the liver is the principal site of synthesis of HF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411770      PMCID: PMC1129260          DOI: 10.1172/JCI111066

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  A clotting artifact in isolated rat liver perfusions.

Authors:  C A Owen; E J Bowie
Journal:  Thromb Res       Date:  1975-11       Impact factor: 3.944

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  THE BIOLOGICAL HALF-TIME OF HAGEMAN FACTOR.

Authors:  J J VELTKAMP; E A LOELIGER; H C HEMKER
Journal:  Thromb Diath Haemorrh       Date:  1965-03-15

4.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

5.  Human factor XII (Hageman factor).

Authors:  J H Griffin; C G Cochrane
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

6.  The role of iron in the regulation of hepatic transferrin synthesis.

Authors:  A G Morton; A S Tavill
Journal:  Br J Haematol       Date:  1977-07       Impact factor: 6.998

7.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

8.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

9.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

Review 10.  Surface-mediated reactions.

Authors:  O D Ratnoff; H Saito
Journal:  Curr Top Hematol       Date:  1979
View more
  3 in total

1.  Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase.

Authors:  E M Gordon; N Venkatesan; R Salazar; H Tang; K Schmeidler-Sapiro; S Buckley; D Warburton; F L Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

2.  Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats.

Authors:  Peter C Papageorgiou; Erik L Yeo; Peter H Backx; John S Floras
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

3.  CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII.

Authors:  Ursula Waack; Mark Warnock; Andrew Yee; Zachary Huttinger; Sara Smith; Ayush Kumar; Alban Deroux; David Ginsburg; Harry L T Mobley; Daniel A Lawrence; Maria Sandkvist
Journal:  mBio       Date:  2018-12-18       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.